Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.

Acta morphologica Hungarica Pub Date : 1992-01-01
M Kalmanti, P Kanavaros, A Sakalidou, M Tzardi, G Datseris, E Bolonaki, T Kalmantis, E Kazlaris, G Delides
{"title":"Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.","authors":"M Kalmanti,&nbsp;P Kanavaros,&nbsp;A Sakalidou,&nbsp;M Tzardi,&nbsp;G Datseris,&nbsp;E Bolonaki,&nbsp;T Kalmantis,&nbsp;E Kazlaris,&nbsp;G Delides","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Paraffin sections from 21 cases of Hodgkin's disease (HD) and 28 cases (26 high-grade and 2 low-grade) of non-Hodgkin's lymphomas (NHL) occurring in childhood were examined for the presence of proliferating cell nuclear antigen using an anti-PCNA antibody. All cases of HD and NHL showed PCNA reactivity. In HD 50.9% (mean value) of Hodgkin and Reed-Sternberg (HRS) cells were PCNA positive and judged to be proliferating. PCNA reactivity was also found in a varying number of cells of the background population in HD (mean value = 11.7%). In NHL 61.2% (mean value) of cells were PCNA positive. In the 26 high grade tumours 63.6% (mean value) of cells were PCNA positive while only 32% (mean value) of cells were PCNA positive in the 2 low-grade tumours. Our results show that the proliferation rate of tumour cells in high-grade NHL is higher than those of tumour cells in low-grade NHL and HRS cells in HD. Moreover, we found a considerable variation of proliferation rate among individual cases of HD (range 31%-68%) of NHL (range 31%-78%). This suggests that PCNA assessment can help in the individual approach of the proliferation rate of each tumour, and, in conjunction with other parameters of the cell proliferation, could be useful for the understanding of the biological behavior of childhood lymphomas.</p>","PeriodicalId":76971,"journal":{"name":"Acta morphologica Hungarica","volume":"40 1-4","pages":"215-21"},"PeriodicalIF":0.0000,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta morphologica Hungarica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Paraffin sections from 21 cases of Hodgkin's disease (HD) and 28 cases (26 high-grade and 2 low-grade) of non-Hodgkin's lymphomas (NHL) occurring in childhood were examined for the presence of proliferating cell nuclear antigen using an anti-PCNA antibody. All cases of HD and NHL showed PCNA reactivity. In HD 50.9% (mean value) of Hodgkin and Reed-Sternberg (HRS) cells were PCNA positive and judged to be proliferating. PCNA reactivity was also found in a varying number of cells of the background population in HD (mean value = 11.7%). In NHL 61.2% (mean value) of cells were PCNA positive. In the 26 high grade tumours 63.6% (mean value) of cells were PCNA positive while only 32% (mean value) of cells were PCNA positive in the 2 low-grade tumours. Our results show that the proliferation rate of tumour cells in high-grade NHL is higher than those of tumour cells in low-grade NHL and HRS cells in HD. Moreover, we found a considerable variation of proliferation rate among individual cases of HD (range 31%-68%) of NHL (range 31%-78%). This suggests that PCNA assessment can help in the individual approach of the proliferation rate of each tumour, and, in conjunction with other parameters of the cell proliferation, could be useful for the understanding of the biological behavior of childhood lymphomas.

增殖细胞核抗原(PCNA)在儿童淋巴瘤中的表达。
用抗pcna抗体检测21例儿童何杰金氏病(HD)和28例(26例高级别和2例低级别)非何杰金氏淋巴瘤(NHL)的石蜡切片是否存在增殖细胞核抗原。所有HD和NHL病例均显示PCNA反应性。在HD中,50.9%(平均值)的Hodgkin和Reed-Sternberg (HRS)细胞PCNA阳性,判断为增殖。在HD背景人群的不同数量的细胞中也发现了PCNA反应性(平均值= 11.7%)。NHL中PCNA阳性细胞占61.2%(平均值)。26例高级别肿瘤中PCNA阳性细胞占63.6%(平均值),2例低级别肿瘤中PCNA阳性细胞占32%(平均值)。我们的研究结果表明,高级别NHL肿瘤细胞的增殖率高于低级别NHL的肿瘤细胞和HD的HRS细胞。此外,我们发现在HD(范围31%-68%)和NHL(范围31%-78%)的个体病例中,增殖率有相当大的差异。这表明,PCNA评估可以帮助每个肿瘤的增殖率的个体方法,并与细胞增殖的其他参数相结合,可能有助于理解儿童淋巴瘤的生物学行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信